Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
(Q37527141)
scientific article published on 21 June 2009
scientific article published on 21 June 2009
Language:
Current Data About
Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
(P31) |
(Q13442814)
|
||||||||
(P304) |
113-138
|
||||||||
(P407) |
(Q1860)
|
||||||||
(P433) |
1
|
||||||||
(P478) |
124
|
||||||||
(P577) |
Sunday, June 21, 2009
|
||||||||
(P921) |
(Q3025883)
|
||||||||
(P1433) |
(Q3378596)
|
||||||||
(P1476) |
"Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors" (language: en)
|
||||||||
(P2093) |
E J Verspohl
|
||||||||
(P13046) |
(Q7318358)
|
other details
description | scientific article published on 21 June 2009 |
External Links
(P356) |
10.1016/J.PHARMTHERA.2009.06.002
|
(P698) |
19545590
|